According to 94% of the C1-INH-HAE patients who used HAE therapy (64/68 patients), the availability of the HAE medication did not change in the analyzed period; 3% stated that the availability improved (2 patients) and 3% said that the availability worsened (2 patients). Here, SERPING1 is linked to hereditary angioedema.